US EditionGlobal Diagnostics Leader Selects Kneat - kneat.com (OTC:KSIOF)
- On May 15, 2025, Kneat entered into a three-year agreement with a U.S.-based clinical diagnostics manufacturer to implement digital solutions for their validation processes.
- The agreement reflects the customer's ongoing dedication to enhancing processes and aligns with the broader industry shift toward adopting digital validation solutions.
- The Company, employing over 14,000 people and operating in 40 countries, will initially use Kneat Gx to digitize equipment validation within its life sciences division.
- Independent evaluations indicate that Kneat’s platform can shorten documentation cycles by as much as 40%, accelerate product launch timelines by up to 20%, and enhance compliance levels.
- This collaboration may increase efficiency and compliance for the manufacturer as more life sciences companies transition from manual to digital validation processes.
11 Articles
11 Articles
Muskoka Region
Global Diagnostics Leader Selects Kneat
LIMERICK, Ireland, May 15, 2025 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTCQC: KSIOF), a leader in digitizing and automating validation and quality processes, is pleased to announce that a manufacturer of clinical diagnostics for the healthcare industry (“the Company”)…
Global Diagnostics Leader Selects Kneat - kneat.com (OTC:KSIOF)
LIMERICK, Ireland, May 15, 2025 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX:KSI) (OTCQC: KSIOF), a leader in digitizing and automating validation and quality processes, is pleased to announce that a manufacturer of clinical diagnostics for the healthcare industry ("the Company") has signed a three-year Master Services Agreement with Kneat. The Company, which is headquartered in the United States, operates in more than 40 countries and employs over …
Coverage Details
Bias Distribution
- 90% of the sources lean Left
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
